Published in Proteomics Weekly, July 9th, 2007
"The current anti-HIV drugs have been developed primarily against subtype B and the effects arising from...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2007-07-09)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.